Concepedia

Michael Bots

MB

Statistics

Publications

38

Citations

2.3K

H-Index

24

Active since

1988

Affiliations

Amsterdam UMC Location University of Amsterdam(Current)

Peter MacCallum Cancer Centre

The University of Melbourne

University Medical Center Utrecht

Amsterdam UMC Location Vrije Universiteit Amsterdam

Michael Bots is an author at Amsterdam UMC Location University of Amsterdam specializing in medicine, life sciences, and oncology.

Publications per year

1988–2024

38

Publications

38

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

John R. Petrie, Nish Chaturvedi, Ian Ford et al. · The Lancet Diabetes & Endocrinology · 2017 · 347 citations · Full text

, , +14

Granzyme B-Dependent Proteolysis Acts as a Switch to Enhance the Proinflammatory Activity of IL-1α

Inna S. Afonina, Graham A. Tynan, Susan E. Logue et al. · Molecular Cell · 2011 · 279 citations · Full text

, , +12

Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors

Michael Bots, Inge Verbrugge, Benjamin Martin et al. · Blood · 2014 · 136 citations · Full text

, , +16

Asymmetric Cell Division of T Cells upon Antigen Presentation Uses Multiple Conserved Mechanisms

Jane Oliaro, Vanessa van Ham, Faruk Sacirbegovic et al. · The Journal of Immunology · 2010 · 123 citations · Full text

, , +17

The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy

Leigh Ellis, Michael Bots, Ralph K. Lindemann et al. · Blood · 2009 · 112 citations · Full text

, , +17

1–5 of 38